• Product nameAnti-HARS antibody [HARSA6]
    See all HARS primary antibodies
  • Description
    Mouse monoclonal [HARSA6] to HARS
  • SpecificityThis antibody reacts with HARS
  • Tested applicationsSuitable for: IHC-P, ICC, IP, Flow Cyt, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    HARS recombinant fragment (Human), containing 50-200 AAs from near the C-terminal.

  • Positive control
    • F2408 whole cell lysate, HeLa cells and HeLa whole cell lysate


  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
  • Storage bufferPreservative: 0.05% Sodium Azide
    Constituents: 1% BSA, PBS
  • Concentration information loading...
  • PurityProtein G purified
  • Purification notesPurified through Protein G, from culture supenatant of hybridoma cultured in a meduim containing bovine IgG-depleted (~95%) fetal bovine serum. Filtered through a 0.22µm membrane.
  • ClonalityMonoclonal
  • Clone numberHARSA6
  • IsotypeIgG1
  • Research areas

Associated products


Our Abpromise guarantee covers the use of ab50835 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use a concentration of 1 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
ICC 1/10.
IP 1/100.
Flow Cyt 1/10. ab170190-Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.
WB 1/100. Detects a band of approximately 50 kDa (predicted molecular weight: 46 kDa).


  • Tissue specificityBrain, heart, liver and kidney.
  • Involvement in diseaseDefects in HARS are a cause of Usher syndrome type 3B (USH3B) [MIM:614504]. USH3B is a syndrome characterized by progressive vision and hearing loss during early childhood. Some patients have the so-called 'Charles Bonnet syndrome,' involving decreased visual acuity and vivid visual hallucinations. USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH3 is characterized by postlingual, progressive hearing loss, variable vestibular dysfunction, and onset of retinitis pigmentosa symptoms, including nyctalopia, constriction of the visual fields, and loss of central visual acuity, usually by the second decade of life.
  • Sequence similaritiesBelongs to the class-II aminoacyl-tRNA synthetase family.
    Contains 1 WHEP-TRS domain.
  • Cellular localizationCytoplasm.
  • Information by UniProt
  • Database links
  • Alternative names
    • cytoplasmic antibody
    • EC antibody
    • FLJ20491 antibody
    • HARS antibody
    • HisRS antibody
    • Histidine tRNA ligase, cytoplasmic antibody
    • histidine translase antibody
    • Histidine tRNA ligase antibody
    • Histidine--tRNA ligase antibody
    • Histidyl tRNA synthetase antibody
    • Histidyl-tRNA synthetase antibody
    • HRS antibody
    • Human histidyl tRNA synthetase homolog (HO3) mRNA complete cds antibody
    • SYHC_HUMAN antibody
    • USH3B antibody
    see all

Anti-HARS antibody [HARSA6] images

  • Anti-HARS antibody [HARSA6] (ab50835) at 1/100 dilution + Hela whole cell lysate at 25 µg

    Mouse IgG antibody at 1/2500 dilution

    Predicted band size : 46 kDa
    Observed band size : 50,100 kDa (why is the actual band size different from the predicted?)
  • ab50835 at a 1/10 dilution staining HARS in Hela cells, using Alexa Fluor®488 Goat Anti-mouse IgG at 1/200 dilution.
  • ab50835 at a 1/10 dilution staining HARS using Alexa Fluor® 488 Goat Anti-mouse IgG at 1/400 dilution.
  • Anti-HARS antibody [HARSA6] (ab50835) at 1/100 dilution + F2408 whole cell lysate at 25 µg

    Mouse IgG antibody at 1/2500 dilution

    Predicted band size : 46 kDa
    Observed band size : 50 kDa (why is the actual band size different from the predicted?)
  • IHC image of ab50835 staining in human cervix formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab50835, 1µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.

    For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.

References for Anti-HARS antibody [HARSA6] (ab50835)

This product has been referenced in:
  • Chen R  et al. Mechanical-stretch of C2C12 myoblasts inhibits expression of Toll-like receptor 3 (TLR3) and of autoantigens associated with inflammatory myopathies. PLoS One 8:e79930 (2013). WB ; Mouse . Read more (PubMed: 24224022) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab50835.
Please use the links above to contact us or submit feedback about this product.